Search Results 1-10 of 169 for CLL

  1. Mayo Clinic offers unique CLL testing and care - Mayo Clinic

    "We understand CLL far better than before."

  2. Malignant fibrous histiocytoma in CLL and Non-Hodgkin lymphoma Videos - Mayo Clinic

    Sign up Related Content Article Mayo Clinic offers unique CLL testing and care

  3. Genetic Epidemiology of CLL Consortium Study - Mayo Clinic Research

    Study eligibility To join the CLL study, a family must have: A living patient with a diagnosis of CLL A blood relative (alive or deceased) diagnosed with CLL Study requirements Families interested in...

  4. Chronic lymphocytic leukemia - Symptoms and causes - Mayo Clinic

    Chronic lymphocytic leukemia (CLL) is a type of cancer of the blood and bone marrow — the spongy tissue inside bones where blood cells are made.

  5. A Study of Hematopoiesis in Patients with Monoclonal B Cell Lymphocytosis (MBL), B-Chronic Lymphocytic Leukemia (CLL), and Healthy Controls - Mayo Clinic

    Study IDs Site IRB Rochester, Minnesota: 16-006204 Sponsor Protocol Number: 16-006204 About this study The purpose of this study is to determine the cellular and mechanistic basis of bone marrow hematopoietic dysfunction in untreated Monoclonal B Cel...

  6. A Study of CG-806 in Patients with Relapsed or Refractory CLL/SLL or Non-Hodgkin's Lymphomas - Mayo Clinic

    Study IDs Site IRB Jacksonville, Florida: 19-008026 Rochester, Minnesota: 19-008026 NCT ID: NCT03893682 Sponsor Protocol Number: APTO-CG-806-01 About this study The purpose of this study is to evaluate the safety, tolerability and effectiveness of CG...

  7. Phase 1/2 Study of TP-0903 (an Inhibitor of AXL Kinase) in Patients With Previously Treated CLL - Mayo Clinic

    TP 0903 was shown to induce apoptosis in CLL B-cells taken directly from patients.TP-0903 was equally potent against CLL cells regardless of risk-factor.

  8. Study of a Triple Combination Therapy, DTRM-555, in Patients With R/R CLL or R/R Non-Hodgkin's Lymphomas - Mayo Clinic

    This study will determine the effectiveness of the triple combination therapy, DTRM-555, in patients with R/R CLL or R/R non-Hodgkin's lymphoma.

  9. A Study Evaluating the Safety and Effectiveness of JCAR017 to Treat Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) - Mayo Clinic

    Study IDs Site IRB Jacksonville, Florida: 19-001564 Rochester, Minnesota: 19-001564 NCT ID: NCT03331198 Sponsor Protocol Number: TRANSCEND CLL 004 About this study The purpose of this study is to determine the effectiveness and safet...

  10. Study to Evaluate Safety and Preliminary Efficacy of MOR208 With Idelalisib or Venetoclax in R/R CLL/SLL Patients Pretreated With BTKi (COSMOS) - Mayo Clinic

    Study IDs Site IRB Jacksonville, Florida: 17-001688 Rochester, Minnesota: 17-001688 NCT ID: NCT02639910 Sponsor Protocol Number: MOR208C205 About this study This is a two-cohort, multicenter, open-label study of MOR00208 combined with idelalisib or v...